Vaccinations

Scientists reveal new vaccine for recurring yeast infections

University of Georgia researchers have successfully created a vaccine that protects and treats vaginal yeast infections in mice.

Study examines immune responses to COVID in patients with antibody deficiencies

A new study aims to explore the immune response to COVID-19 infection and vaccination in patients with antibody deficiencies.

Why COVID vaccine development was exceptionally speedy

Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.

COVID-19 vaccine does not damage placentas

Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.

Immune system research: Vaccines and immunotherapeutics

Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.

Nepal faces 1200% increase in COVID cases

Nepal, which shares a long border with hard-hit India, is experiencing a meteoric rise in COVID-19 cases and facing an oxygen shortage.

Testing must go hand-in-hand with vaccines to come out of the crisis

COVID-19 testing must go hand-in-hand with the vaccines in order for the UK to come out of the crisis successfully.

What happens now that the US supports the TRIPS waiver?

Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.

Research reveals five reasons behind UK vaccine hesitancy

New data explores why some in the UK continue to experience vaccine hesitancy - with one man explaining that "it is human nature to have second thoughts".

Under 40s will be offered an alternative to the Astrazeneca vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all under 40s should be offered an alternative to the Oxford/AstraZeneca vaccine following blood clot risk.

European Commission hesitates on TRIPS waiver for pandemic

The European Commission on Thursday (6 May) responded to a US declaration of support for the TRIPS waiver, stating that they were open to further discussions without explicit agreement.

Dementia patients should be given priority for the COVID-19 vaccine

Alzheimer Europe has issued a call for people with dementia and their carers to be given priority for the COVID-19 vaccine.

Only 41% of people are willing to sign up for COVID-19 vaccine trials

New research from the University of Birmingham shows that only 41% of people would be willing to sign up for COVID-19 vaccine trials.

CureVac mRNA vaccine can be stored at normal fridge temperature

The CureVac mRNA vaccine is currently in final stages of clinical trials - but it is expected to perform like Pfizer and Moderna, with the bonus of surviving at ordinary refrigeration temperatures.

Countries denied access to vaccines they helped develop

A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.

US declares support for TRIPS waiver on COVID vaccines

The TRIPS waiver would temporarily stop an intellectual property law that stops poorer countries to manufacture the vaccine - the US now joins India and South Africa in the proposal.

Fully vaccinated UK adults to get COVID booster dose in 2021

Adults over the age of 50 in the UK could get the COVID booster dose in 2021 - the third dose of the vaccine could be given as soon as Autumn.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders